Calculation of the radioimmunoassay Standard curve by "spline
Transcription
Calculation of the radioimmunoassay Standard curve by "spline
RADIOIMMUNOASSAY AND R E L A T E D PROCEDURES IN M E D I C I N E VOL. I PROCEEDINGS SERIES RADIOIMMUNO ASSAY A N D R E L A T E D PROCEDURES IN MEDICINE P R O C E E D I N G S O F A SYMPOSIUM ON RADIOIMMUNOASSAY AND R E L A T E D P R O C E D U R E S IN C L I N I C A L MEDICINE AND R E S E A R C H HELD BY THE I N T E R N A T I O N A L ATOMIC E N E R G Y A G E N C Y IN I S T A N B U L , 10 - 14 S E P T E M B E R 1973 In two volumes VOL.I I N T E R N A T I O N A L ATOMIC E N E R G Y A G E N C Y VIENNA, 1974 ' ~ The following States are Members of the International Atomic Energy Agency: AFGHANISTAN ALBANIA HAITI HOLY SEE PAKISTAN PANAMA ALGERIA HUNGARY PARAGUAY ARGENTINA ICELAND INDIA AUSTRALIA AUSTRIA BANGLADESH BELGIUM INDONESIA IRAN IRAQ PERU PHILIPPINES POLAND PORTUGAL BOLIVIA IRELAND ROMANIA SAUDI ARAB1A BRAZIL BULGARIA ISRAEL SENEGAL ITALY IVORY COAST JAMAICA SIERRA LEONE SINGAPORE JAPAN JORDAN SPAIN BURMA BYELORUSSIAN SOVIET SOCIALIST REPUBLIC CAMEROON CANADA SOUTH AFRICA SRI LANKA SUDAN CHILE COLOMBIA KENYA KHMER REPUBLIC KOREA, REPUBLIC OF COSTA RICA CUBA KUWAIT SYRIAN ARAB REPUBLIC LEBANON LIBERIA THAILAND LIBYAN ARAB REPUBLIC TURKEY CYPRUS CZECHOSLOVAK SOCIALIST REPUBLIC DENMARK DOM IN ICAN REPUBLIC ECUADOR EGYPT, ARAB REPUBLIC OF EL SALVADOR / ETHIOPIA FINLÄND FRANCE GABON GERMAN DEMOCRATIC REPUBLIC SWEDEN SWITZERLAND TUNISIA LIECHTENSTEIN UGANDA LUXEMBOURG MADAGASCAR MALAYSIA UKRAINIAN SOVIET SOCIALIST REPUBLIC MALI MEXICO MONACO MONGOLIA MOROCCO NETHERLANDS NEW ZEALAND UNION OF SOVIET SOCIALIST REPUBLICS UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND UNITfcD STATES OF AMERICA URUGUAY VENEZUELA GERM AN Y , FEDERAL REPUBLIC OF GHANA NIGER VIET-NAM NIGERIA YUGOSLAVIA GREECE GUATEMALA NORWAY ZAIRE, REPUBLIC OF ZAMBIA The Agency' s Statute was approved on 23 October 1956 by the Conference on the Statute of the IAEA held at United Nations Headquarters, New York; it entered into force on 29 July 1957. The Headquarters of the Agency are situated in Vienna. Its principal objective is "to accelerate and enlarge the contribution of atomic energy to peace, health and prosperity throughout the world". Printed by the IAEA in Austria March 1974 CORRIGENDUM RADIOIMMUNOASSAY AND R E L A T E D P R O C E D U R E S IN M E D I C I N E , V O L . I. (STI/PUB/350) Paper IAEA-SM-177/87 by Badawi et a l . Page 417, line 7 F o r M R X 71/222 read M R C 71/222 Page 417, lines 8 - 1 1 The sentence should be as follows: It was also found that 1.0 milli-ampoule of the serum Standard M R C 71/167 was equivalent to 0.09 ng and 0. 9 of pituitary Standard M R C 71/222 with 95% fiducial limits at 0.06 - 0.14 and 0.6 - 1.4, respectively. RADIOIMMUNOASSAY AND R E L A T E D P R O C E D U R E S IN MEDICINE I A E A , VIENNA, 1974 STI/PUB/350 CONTENTS OF VOL. I 3 T A N D A R D I Z A T I O N AND C O N T R O L OF R E A G E N T S A N D P R O C E D U R E S (Session I) Heterogeneity of peptide hormones: its implications for radioimmunoassay (IAEA-SM-177/213) Rosalyn S. Y a l o w Discussion * Some problems of specific antibody production in radioimmunoassay techniques (IAEA-SM-177/5) Katalin M e r e t e y and L . T. K o c s a r Discussion A comparative assessment of immunisation procedures for radioimmunoassay (IAEA-SM-177/10) Susan L a d e r , B. A . L . H u r n and G. C o u r t Discussion Problems of optimization of double antibody radioimmunoassay of H L H , HFSH and H G H : "hook" phenomenon, false negative patient values and linearity of values from patient plasma dilutions (IAEA-SM-177/52) E . W . J o e l , D . K . S c h ö n b e r g , W. I l g and E. K e l l e r Discussion Preparation of human protein hormones for use in radioligand assays: structure-function considerations (IAEA-SM-177/209) . . . L. E. R e i c h e r t , Jr. Discussion Standards and reference reagents for radioimmunoassay of peptide hormones and related substances (IAEA-SM-177/205) . . . . P. M a r y C o t e s Discussion ASSAY A U T O M A T I O N ; D A T A A N A L Y S I S . ASSAYS (Session II) 3 21 23 29 31 44 45 57 59 69 71 85 IMMUNORADIOMETRIC Automation of radioimmunoassay and other Saturation assay procedures (IAEA-SM-177/206) R. P . E k i n s Discussion Calculation of the radioimmunoassay Standard curve by "spline function" (IAEA-SM-177/71) I. M a r s c h n e r , F . E r h a r d t and P . C . S c r i b a Discussion Rapid assay for luteinizing hormone and evaluation of data by new Computer program (IAEA-SM-177/80) J. S p o n a 91 108 111 120 123 New developments i n the immunoradiometric assay (IAEA-SM-177/204) G. M . A d d i s o n Discussion Properties of two-site immunoradiometric (labelled antibody) assay S y s t e m s (IAEA-SM-177/21) L . E . M . M i l e s , C. P . B i e b e r , L . F . E n g and D . A . L i p s c h i t z Discussion Statistical analysis of radioimmunoassays and immunoradiometric (labelled antibody) assays: a generalized, 131 147 149 163 weighted, i t e r a t i v e , l e a s t - S q u a r e s method for l o g i s t i c curve fitting (IAEA-SM-177/208) D. R o d b a r d and D . M . H ü t t Discussion 165 189 G L Y C O P R O T E I N HORMONES (Session III) Radioimmunoassays o f glycoprotein hormones (IAEA-SM-177/201). . P. F r a n c h i m o n t , J . C. H e n d r i k , Aimee-Marguerite R e u te r and H. G. B u r g e r Discussion Dosage radioimmunologique de l'hormone thyreotrope dans l'hypophyse et dans l e sang du rat: des variations de concentration s o u s l'effet de differents traitements (IAEA-SM-177/7) Ligia S i m i o n e s c u , V. S ä h l e a n u , Maria O p r e s c u et V i c t o r i a O r b e ^ t e a n u Discussion Radioinmunoanalisis de tirotrofina humana: relacion materno-fetal en l a altura (IAEA-SM-177/40) M. P a r ede s-Su ä r ez y J. V a r e a T e r ä n Immunological cross-reactions of L H and H C G : contributions of the subunits and of the conformation of the native hormone (IAEA-SM-177/58) H . S. J a c o b s , Caroline V a n t h u y n e and R. P . E k i n s Discussion Immunological identity of antibodies against urinary and pituitary follicle-stimulating hormone (IAEA-SM-177/91) V . O l i v i e r i , G. R i c c i and P . D o n i n i Discussion Comparaison de differentes methodes de dosage radioimmunologique des gonadotrophines (IAEA-SM-177/6) Aimee-Marguerite R e u t e r , J . C . H e n d r i c k , H . B e c k e r et P . F r a n c h i m o n t Discussion Diagnostic use of a radioreceptor assay for human chorionic gonadotropin (IAEA-SM-177/81) M . T a l ä s and A . R. M i d g l e y , J r . 195 210 6tude 213 219 221 237 242 245 250 253 264 267 Radioimmunoassay of human erythropoietin (IAEA-SM-177/19) J. F. G a r c i a Discussion 275 286 P E P T I D E HORMONES (Sessions IV and V) Standardization of radioimmunoassay technique for determination of plasma insulin and growth hormone (IAEA-SM-177/84) Olga Z a z u c o H i g a , Iracelia T o r r e s de T o l e d o e S o u z a , B. L . W a j c h e n b e r g , Heidi P i n t o and R. R i b e i r o P i e r o n i Radioimmunological behaviour of endogenous and exogenous human growth hormone (IAEA-SM-177/9) K. v o n W e r d e r , C. D e s a l m , S. G a l l e n be r ge r , M . G o t t s m a n n and P . C . S c r i b a Discussion Degradation of labelled hormone i n radioimmunoassay of A C T H (IAEA-SM-177/37) E . V i r a s o r o , G. C o p i n s c h i and O . D . B r u n o Discussion Dosage radioimmunologique de l'hormone parathyroidienne plasmatique chez l'homme (IAEA-SM-177/64) J. G u e r i s A radioimmunoassay for human serum parathyroid hormone: methods and c l i n i c a l evaluation (IAEA-SM-177/82) R. B o u i l l o n , P . K o n i n c k x and P. D e M o o r Dosage radioimmunologique de l a calcitonine humaine (IAEA-SM-177/8) G. H e y n e n , P . F r a n c h i m o n t et S. G a s p a r Discussion Dosage radioimmunologique de l a calcitonine humaine: etude immunochimique et comparaison des resultats avec ceux du dosage biologique (IAEA-SM-177/62) M . S. M o u k h t a r , A . J u l l i e n n e , P. R i v a i l l e et G. M i l h a u d Discussion Dosage radioimmunologique de l a gastrine — mise au point du dosage et resultats cliniques (IAEA-SM-177/65) H. K a e s s et Brigitte M e r i a d e c Discussion Comparative evaluation of radioimmunoassay methods for human prolactin using anti-ovine and anti-human prolactin sera (IAEA-SM-177/87) M . B a d a w i , S. B i l a , M . L ' H e r m i t e , F . R. P e r e z - L o p e z and C. R o b y n Discussion Radioimmunoassay of angiotensin II (IAEA-SM-177/23) R. L . W o l f , Cornelia E . G h e r m a n and M . M e n d l o w i t z Discussion 2 91 309 321 323 335 337 353 367 380 381 397 399 409 411 421 423 427 Simplified radioimmunoassay for plasma angiotensin II (IAEA-SM-177/54) J . N u s s b e r g e r , R. B e c k e r h o f f , W. V e t t e r , H. A r m b r u s t e r and W. S i e g e n t h a l e r Dosage radioimmunologique des Prostaglandines F dans le plasma (IAEA-SM-177/68) , B. C h a r b o n n e l , A . S o u b r i e r et F . D r a y Discussion Immunological and biological specificity of a radioimmunoassay for Prostaglandins of the F group (PGF) (IAEA-SM-177/92) C. P a t r o n o and G. C i a b a t t o n i Discussion Radioimmunoassay of the hypothalamic releasing hormones, L H - R H and T R H , in blood and urine (IAEA-SM-177/24) S . L . J e f f c o a t e , H , M . F r ä s e r , A . G u n n , D. T. H o l l a n d and N. W h i t e Discussion 429 a Chairmen of Sessions and Secretariat of the Symposium 437 450 451 460 463 46 7 471 IAEA-SM-177/71 CALCULATION OF THE RADIOIMMUNOASSAY STANDARD CURVE BY "SPLINE FUNCTION"* I. MARSCHNER, F. ERHARDT, P . C . SCRIBA II. Medizinische Klinik der Universität München, Munich, Federal Republic of Germany Abstract CALCULATION OF THE RADIOIMMUNOASSAY STANDARD CURVE BY "SPLINE FUNCTION". A project was proposed to fülly automate radioimmunoassay. Firstly a Computer program was applied to the calculation of the Standard curve without distortion of its sigma form. This mathematical process, called "smoothing by spline function", has been applied recently for technical and physical purposes, and calculates trial functions between points on the Standard curve, whereby the curve Segments on their common end points and their first and second differentials are steady and the total curve has minimal oscillation. The count-rates are fed off-line by paper-tape into a Siemens 404/3 Computer. A plotter draws a semilogarithmic graph of the coordinates, sets the calculated Standard curve and plots the Standard deviation of the points. The smoothing parameter is selectable, and points which are in error can be corrected or eliminated for each case. After examination of the Standard curve and eventual correction, the calculation of the hormone concentration of the unknowns is processed by the second part of the program. 1. INTRODUCTION The n u m b e r of h o r m o n e d e t e r m i n a t i o n s by r a d i o i m m u n o a s s a y and c o m p e t i t i v e p r o t e i n - b i n d i n g , both f o r r e s e a r c h and r o u t i n e c l i n i c a l p u r p o s e s , i s i n c r e a s i n g a l m o s t e x p o n e n t i a l l y . Consequently, e v e r y e f f o r t has b e e n m a d e to r e p l a c e the w i d e s p r e a d but v e r y t i m e - c o n s u m i n g " c l a s s i c a l " g r a p h i c evaluation of u n k n o w n s , w h e r e one u s e s a h a n d - d r a w n S t a n d a r d c u r v e , by a m a t h e m a t i c a l a p p r o a c h . In a p r o j e c t to a u t o m a t e r a d i o i m m u n o a s s a y c o m p l e t e l y , we u s e a C o m p u t e r p r o g r a m w h i c h is r e m a r k a b l y d i f f e r e n t f r o m m e t h o d s u s e d so far. 2. M A T H E M A T I C A L BASIS OF T H E S P L I N E A P P R O X I M A T I O N Since radioimmunoassay i n v o l v e s the use of experimental data that are s u b j e c t to a c c i d e n t a l and s y s t e m a t i c e r r o r s , t h e r e is a d i s a d v a n t a g e in u s i n g a S i n g l e i n t e r p o l a t i o n of the m e a n v a l u e s of the r e s p o n s e m e t a m e t e r ( f r o m h e r e on r e f e r r e d to as points) of a S t a n d a r d d o s e - r e s p o n s e c u r v e , e v e n w i t h functions of a higher d e g r e e . It w o u l d t h e r e f o r e p r o b a b l y be b e t t e r to do some smoothing i n a mathematically founded and reproducible w a y . For t h i s p u r p o s e , s m o o t h i n g by s p l i n e functions is a v e r y u s e f u l m e t h o d . Smoothing by s p l i n e functions has b e e n u s e d w i t h g r e a t success i n the c a l c u l a t i o n of c o m p l i c a t e d c u r v e s f o r t e c h n i c a l and p h y s i c a l p u r p o s e s a n d i n C o m p u t e r - a i d e d d e s i g n . The p r e m i s e of t h i s is that the c o o r d i n a t e s e i t h e r i n c r e a s e o r d e c r e a s e s t e a d i l y i n r e l a t i o n to one a n o t h e r , as is the c a s e i n r a d i o i m m u n o a s s a y , and a r e not r a n d o m l y d i s t r i b u t e d . In s h o r t , * Supported by the Bundesministerium für Bildung und Wissenschaft (St. Sch. 610) and the Deutsche Forschungsgemeinschaft (SFB 51). 111 112 MARSCHNER et a l . the m a t h e m a t i c a l b a s i s of this m e t h o d , i n v e n t e d b y Reinsen [ 1 - 3 ] , c a n be e x p r e s s e d as f o l l o w s : The s m o o t h i n g funetion f(x) to be c o n s t r u e t e d s h a l l m i n i m i z e the i n t e g r a l of the s e c o n d d e r i v a t i v e of g(x) ( e x p r e s s i o n 1) a m o n g a l l functions g(x), s u c h that the s u m of g(Xf) - y i d i v i d e d by 6yi, a l l to the p o w e r two, i s less t h a n o r equal to S ( e x p r e s s i o n 2), w h e r e S i s defined b y e x p r e s s i o n 3. In o u r c a s e Xj i s the c o n c e n t r a t i o n of c o l d h o r m o n e and yi Stands f o r % bound of x r e l a t e d to m a x i m a l b i n d i n g i n the a b s e n c e of c o l d h o r m o n e (Bo). i t J g" (x) dx (1) N - (2N)* i S a + (2N)* (3) 2 xo i =0 w h e r e N = the n u m b e r of p o i n t s . In e x p r e s s i o n (3), S depends o n the n u m b e r of p o i n t s ( d e t e r m i n e d by d i f f e r e n t c o n c e n t r a t i o n s of c o l d h o r m o n e ) of the S t a n d a r d c u r v e . In o t h e r w o r d s , the d e f i n i t i o n of o p t i m a l s m o o t h i n g c a n be e x p r e s s e d a s f o l l o w s : S w i l l be c h o s e n s o that the a r e a u n d e r the s e c o n d d e r i v a t i v e of the c u r v e , a s a m e a s u r e o f the o s c i l l a t i o n o f the w h o l e f u n e t i o n , w i l l be m i n i m i z e d . That m e a n s , f i n a l l y , that the c u r v e s e g m e n t s b e t w e e n the p o i n t s of a S t a n d a r d c u r v e a r e d e s c r i b e d by S i n g l e t r i a l functions of the c o m m o n equation: f(x) - aj The + bi(x - xj) + Cl(x - X i ) + 2 d (x t X i ) 3 (4) parameters, a j , b j , c i and d[, b e g i n n i n g w i t h the p a r a m e t e r s of a r e v a r i e d i n a n i t e r a t i o n s l o p e u n t i l the second d e r i v a t i v e o f the c u r v e s e g m e n t s on t h e i r c o m m o n end p o i n t s a r e c o n t i n u o u s : f r o m t h i s , by d e f i n i t i o n , f o l l o w s the c o n t i n u i t y of the whole s p l i n e f u n e t i o n and its first derivative. Euler-Lagrange, The d e g r e e of s m o o t h i n g of the c u r v e i s i n f l u e n c e d , f i r s t l y , by öy^ ( e x p r e s s i o n 2) w h i c h i s the e s t i m a t i o n of the S t a n d a r d d e v i a t i o n of the S i n g l e v a l u e s of one p o i n t a n d , s e c o n d l y , by the p a r a m e t e r S ( e x p r e s s i o n s 2 and 3). In o u r p r o g r a m we c a n i n f l u e n c e the s m o o t h i n g p a r a m e t e r b y a n a d d i t i o n a l f a c t o r using the C o m p u t e r t e r m i n a l . In t h i s w a y , greater v a r i a b i l i t y is a c h i e v e d e n a b l i n g , f o r e x a m p l e , d i f f e r e n t p a r a m e t e r s to be t e s t e d and the best one f o r r a d i o i m m u n o a s s a y S t a n d a r d c u r v e s to be found by S t a t i s t i c a l means. It s h o u l d be s t r e s s e d that the S t a n d a r d d e v i a t i o n of the S i n g l e v a l u e s , r e l a t i v e l y w e i g h t e d a s Öy i # i n f l u e n c e s the s m o o t h i n g a n d , c o n s e q u e n t l y , the c o u r s e of the f u n e t i o n . That m e a n s that the p o i n t s w i t h l e s s s c a t t e r i n g o f t h e i r S i n g l e v a l u e s w i l l be treated as s t r o n g e r and the c u r v e w i l l r u n n e a r t h e i r mean v a l u e , the d i s t a n c e d e p e n d i n g on the o t h e r p o i n t s next to i t . On the o t h e r h a n d , v a l u e s w i t h l a r g e s c a t t e r i n g (that m a y be due to e r r o r s i n p i p e t t i n g the tracer o r i n s e p a r a t i n g bound f r o m f r e e h o r m o n e ) w i l l be a l m o s t i g n o r e d b e c a u s e of t h e i r r e l a t i v e l y less i m p o r t a n c e ( i . e . w h e n övj i s l a r g e ) . In t h i s w a y i t i s u n n e c e s s a r y to c o r r e c t S i n g l e false v a l u e s (rogue r e a d i n g s ) b e c a u s e they do not i n f l u e n c e the c o u r s e of the c u r v e . IAEA-SM-177/71 3. 3.1. 113 D E S C R I P T I O N OF T H E R U N OF T H E P R O G R A M P e s c r i p t i o n of the Computer A Siemens 404/3 Computer with a core of 48 K was used. It was provided with a disc with random access. A terminal, a punched tape reader, a punch and a plotter (Hagen-Graphomat, Hägen-Systems, F r a n k f u r t / M . , F e d e r a l Republic of Germany) with a maximal drawing format of 840 to 600 mm were also used. FIG. 1. Standard curve for LH that has been calculated and plotted by using the spline approximation. Ordinate: percentage of bound hormone expressed as B/B . Abscissa: concentration of cold hormone expressed on a logarithmic scale. The horizontal line at 95% is the limit of detection, defined by Kaiser as three Standard deviations of B . In this case the leastdetectabledose is about 0.02 ng/100 u l . 0 0 114 3.2. MARSCHNER et a l . Data input The t r a n s f e r of data between the g a m m a - c o u n t e r (Gamma-Guard, F a . T r a c e r - L a b , Mechelen, Belgium) and the C o m p u t e r is done off-line by paper-tape. Therefore every gamma-counter is equipped with a Teletype (ASR 33) with paper-tape output. A l l the count-rates of the assay, beginning with the S t a n d a r d curve, c o n t r o l - s a m p l e s and unknowns, are read f r o m paper-tape and s t o r e d on the disc. False data may be corrected, i f necessary, by a subroutine. Necessary Information about the concentrations of cold hormone used i n the S t a n d a r d curve and the number of tubes containing no cold h o r m o n e (Bo), cold h o r m o n e (duplicates, t r i p l i c a t e s , e t c . ) , 0.30 0.78 1.56 3.13 625 12.5 25.0 50.0 100.0 yu units TSH/ml FIG.2. Example of the effect of various smoothing factors. The lowest measure-point (0.39 uU TSH/ml) of this TSH dose-response curve is a pipetting error. concentration is higher and the precision is poor. this point is increasingly ignored. The true With increasing smoothing factors (0.05, 0.5 and 1.5) Despite this, the usable part of the curve remains almost unaffected. 115 IAEA-SM-177/71 and no first antibody (N) are read i n the paper-tape reader from a short second paper-tape, called the specification-strip. With this Information, the Computer is able to find the corresponding data on the disc and calculate the Standard curve. 3.3. Calculation and plotting of the Standard curve The S t a n d a r d curve takes about two seconds to calculate. The program allows us to decide whether or not we want the plotter to draw a 40 c m X 5 0 c semilogarithmic graph of the coordinates before plotting the S t a n d a r d curve ( F i g . 1). Aiternatively, results may be calculated without use of the plotter. In each case one must decide on a smoothing factor. The plotting of the Standard curve with various smoothing factors can be repeated as often as required ( F i g . 2). Different Standard curves can also be plotted i n the same graph of the coordinates to show, for example, the between-assay Variation of S t a n d a r d curves. Düring plotting, Table I i s printed out. After this part of the program has been stopped ( i . e. after the bestfitting smoothing factor has been found: for routine purposes we only use 0. the matrix containing the parameters a i , b i , ci and di for every t r i a l funetion is stored in the d i s c . Provided that the recovery curve ( i . e. a S t a n d a r d curve i n serum with a low or immeasurable hormone level) is contained i n the same assay it may be s i m i l a r l y processed. In this way we can calculate the regression coefficient between two selectable segments of the S t a n d a r d curve. With this regression coefficient or recovery factor the results of the unknowns can be adjusted [ 4 ] . T A B L E I. T Y P I C A L P R I N T - O U T O F I N F O R M A T I O N Y I E L D E D B Y T H E C O M P U T E R A F T E R T H E "SMOOTHING" C A L C U L A T I O N This table, which is related to the curve in Fig. 1, is printed out at the same time as the curve is plotted. Column Column Column Column 1: 2: 3: 4: Hormone concentration of Standards. Ordinate, calculated by spline approximation. Mean value of the Single points. Estimaüon of the Standard deviation of the Single values (yj). Column 5: Differences between values in columns 2 and 3. SDIF: Sum of values in column 5. SDIF increases with increasing smoothing factor. ABSZISSE ORDINATE 0.00 0.02 0.05 0.10 0.20 0.50 1.00 2.00 5.00 100.09 94.55 84.90 67.30 39.09 17.33 11.06 7.21 4.73 SDIF 2.90 MITTELWERT ABW 100.00 94.50 83.72 67.56 38.31 17.26 11.35 7.05 4.74 1.70 0.50 2.51 0.36 0.64 1.52 0.88 1.21 0.45 DI FF 0.09 0.05 1.13 0.27 0.78 0.07 0.30 0.16 0.01 116 MARSCHNER et a l . T A B L E II. E X A M P L E O F PRINTING T H E R E S U L T S AS D E S C R I B E D IN S E C T I O N 3.4(a) Column 1: Sample number. Column 2: Count rate. Column 3: Bound as < % of B . Column 4: Hormone concentration. 0 PLATZNR. 100 101 102 103 104 105 106 107 108 109 110 CPM 5381 3605 4075 4007 3868 4075 4049 3B85 3*93 3789 4134 PROZ. 34.10 16.05 20.83 20.13 18.72 20.83 20.56 18.89 14.91 17.92 21.42 HORM.KONZ. 1.93 4.45 3.45 3.58 3.86 3.45 3.49 3.82 4.71 4.03 3.34 T A B L E III. E X A M P L E OF HOW T H E R E S U L T S A R E P R I N T E D AS D E S C R I B E D IN S E C T I O N 3. 4(b) The first line contains the serum number, time of venipuncture, name of patient, date of birth and diagnosis. The results of a TRH-Stimulation test, seen as two lots of triplicates, have been taken from a hypothyroid patient with endemic goitre. The upper triplicate group are the TSH values measured before TRH administration (mean in the upper right-hand corner) and the lower group, the TSH levels, 30 min after an intravenous injection of 200 ug TRH (mean lower right-hand side). 805 805 0 ZANKL, RUDOLF 17.11.32 82 83 84 8201 8146 8099 78V8 78.2 77.7 6V64 6V78 6.90 30 85 86 87 2608 2658 2679 18.6 19V1 19.3 41V64 40V33 39.81 STRUMA 6.77 40.59 3. 4. Calculation of the unknowns and printing of the results To calculate the hormone concentrations of an unknown sample we use a second program which again reads the parameters a^ b c and d from the d i s c . F o r data input we can choose between disc (which is the normal case), paper-tape reader, or terminal. After reading one S i n g l e count-rate, the appropriate curve segment is ascertained. Then the hormone concentration i s calculated by linear iteration, which i s continued until the value is approximated to four decimal places. i 9 4 4 117 IAEA-SM-177/71 The results can be printed in two ways: (a) (b) Line by line after stipulating the first and the last desired sample number (Table II), By reading a paper-tape which contains the serum number, the position number of the samples with the same serum (duplicates, triplicates, e t c . ) , the time of venipuncture (e. g. before or after application of a releasing hormone), the patient's name and any additional Information like the diagnosis. Compared with the f i r s t way, Table III shows an additional heading with the specifications and the mean hormone concentration of S i n g l e values belonging to i t . With this method, probe identification is facilitated. BC/.) 100 90 90 60 \ 70 SPLINE 60 L0G1T \ \\ 50 40 \ V \ 10 \ 0.5 1.0 2.0 50 10.0 20.0 500 \ \\ 30 20 \ 10 0.5 1.0 2.0 5.0 10.0 20.0 50.0 ngFSH/ml FIG.3. Comparison of logit transformation and spline approximation on a FSH dose*response curve. Logit transformation gives a sausfactory result only when there is an approximately linear gradient in the middle ränge of the Standard curve. 118 4. MARSCHNER et a l . DISCUSSION The approximation of radioimmunoassay S t a n d a r d curves by spline functions is a considerable improvement in the automatic calculation of assay data and unknown hormone concentrations. It is very important that (a) the sigma f o r m of this S t a n d a r d c u r v e does not show any distortion and (b) the whole curve is calculated from 100% B/Bo to any required concentration of cold hormone. A systematic e r r o r i s , of course, possible, but this remains at the same low l e v e l throughout the whole ränge and does not increase at either end of the curve, as is the case in logit transformation [ 5 ] . There is no pre-established funetion to which the S t a n d a r d curve has to conform ( e . g . parabola, arcus-sinus), but rather it is fitted in a previously defined "optimal" way to the points. It should be emphasized that spline approximation is not a chance procedure, as are logit transformation [ 6 - 8 ] , arcus-sinus transformation [ 9 ] , and hyperbolic or parabolic r e g r e s s i o n [ 1 0 ] . In fact, we have compared two types of commonly occurring S t a n d a r d curves by using both logit transformation and spline approximation. The usual type of S t a n d a r d curve w i t h an a p p r o x i m a t e l y l i n e a r g r a d i e n t in the middle ränge gives a satisfactory logit transformation. However, i n some cases, as w i t h the S t a n d a r d curve for FSH shown in F i g . 3, the spline f u n e t i o n m e t h o d is c l e a r l y s u p e r i o r to the l o g i t t r a n s f o r m a t i o n . The advantage of spline funetion is that it can be applied to a l l types of curves found i n radioimmunoassay. Furthermore, the mathematical derivation of spline-approximation has nothing to do with the theoretical fundamentals of radioimmunoassay [ 5, 11, 1 2 , 1 3 ] . Rather, it is a method by which one is able to calculate from points (at least duplicates, because of the relative weight) the best-fitting curve and therefore it is not dependent on the characteristics of the antibody. The p r e c i s i o n of approximation increases with the number of points on the Standard curve. This too is an important advantage over the other methods mentioned previously because we do not necessarily get a better fitting with these other methods if we have more points on the c u r v e . The accuraey of the spline-approximation is easy to demonstrate by the following e x a m p l e ( F i g . 4). B y using a s i m p l e p r o g r a m , the C o m p u t e r p l o t t e d a sinus curve. The abscissa from tt/2 to 3 n / 2 was divided into 100 equal divisions. F r o m every tenth division an imaginary perpendicular was drawn and the value of the ordinate of its point of intersection w i t h the curve was calculated. F o r each value an a r b i t r a r y ränge was assigned by calculating the values for perpendiculars one division apart from either side of that corresponding to a given tenth division. By using spline functions the C o m p u t e r drew a curve t h r o u g h these ranges. A s can be seen f r o m the figure these curves are a l m o s t identical. The plotting of the c o o r d i n a t e s as well as the c a l c u l a t i o n of the S t a n d a r d curve i n a semilogarithmic graph corresponds to the c l a s s i c a l procedures of radioimmunology [ 1 1 , 1 4 ] . Because of the described weighting of the measure-points by the estimation of the S t a n d a r d deviation, correction of e r r o r s is only necessary when there is good precision and poor accuraey ( e . g . false concentration of the S t a n d a r d and good pipetting precision). The possibility of calculating the regression between S t a n d a r d curves in buffer and i n s e r u m (recovery curves) allows a systematic adjustment of the unknowns. 119 IAEA-SM-177/71 B(V.) 1.56 FIG.4. Original sinus curve and its approximation by spline functions. (See Section 4 for a description.) A technician would r e q u i r e a p p r o x i m a t e l y one day to evaluate an assay with 800 unknowns. The C o m p u t e r does the calculation within 5 seconds and prints the results i n 20 minutes. Since the introduction of this program, radioimmunoassays and competitive protein-binding assays are routinely c a r r i e d out i n our Endocrinology Department on the following substances: thyroid-stimulating hormone, Insulin, luteinizing hormone, growth hormone, thyroxine, tri-iodo-thyronine, follicle-stimulating hormone, antidiuretic hormone and angiotensin I. REFERENCES [1] [2] REINSCH, C . H . , REINSCH, C . H . , Smoothing by spline functions, Numer. Math. 10 (1967) 177. Smoothing by spline functions II. Numer. Math. 16 (1971) 451. 120 MARSCHNER et a l . [3] REINSCH, C . H . , Mathematische Hilfsmittel für das automatische Zeichnen von Funktionen und Kurven. Ges. f. Informatik, Ber., No.2, p. 309. Fachtagung Computer Graphics, Berlin 19-21 Oct. 1971. [4] ERHARDT, F . , MARSCHNER, I., PICKARDT, R . C . , SCRIBA, P . C . , Verbesserung und Qualitätskontrolle der radioimmunologischen Thyreotrophin-Bestimmung, Z . K l i n . Chem. K l i n , Biochem. (in press). [5] [6] [7] RODBARD, D . , RAYFORD, P . L . , COOPER, J . A . , ROSS, G . T . , Statistical quality control of radioimmunoassays, J. C l i n . Endocrinol. Metab. 28 (1968) 1412. HEALY, M . J . R . , Statistical analysis of radioimmunoassay data, Biochem. J. JL30 (1972) 207. RODBARD, D . , LEWALD, J . E . , Computer analysis of radioligand assay and radioimmunoassay data, [8] Acta Endocrinol. Suppl. W7 (1970) 64. RODBARD, D . , "Statistical aspects of radioimmunoassay", Principles of Competitive Protein Binding Assay, Chap. VIH (ODELL, W . D . , DAUGHADAY, W . H . , Eds), J.B. Lippincott C o . , Philadelphia and Toronto (1971) 204. VIVIAN, S.R., LA BELLA, F . S . , Classic bioassay Statistical procedures applied to radioimmunoassay of bovine thyrotropin, growth hormone and prolactin, J. C l i n . Endocrinol. Metab. 3 3 (1971) 225. [10] TÄLJEDAL, I.B., WOLD, S., Fit of some analytical functions to insulin radioimmunoassay Standard curves, Biochem. J. J19 (1970) 139. [11] BERSON, S . A . , YALOW, R . S . . General principles of radioimmunoassay, C l i n . C h i m . Acta 22 (1968) 51. [9] [12] FELDMANN, H . , RODBARD, D . , "Mathematical theory of radioimmunoassay", Principles of Competitive Protein Binding Assay, Chap. V E (ODELL, W . D . , DAUGHADAY, W . H . , Eds), J.B. Lippincott C o . , Philadelphia and Toronto (1971) 158. [13] RODBARD, D . , BRIDSON, W . , RAYFORD, P . L . , Rapid calculation of radioimmunoassay results, J. Lab. C l i n . Med. 74 (1969) 770. [14] YALOW, R.S., BERSON, S . A . , "Introduction and general considerations", Principles of Competitive Protein Binding Assay, Chap.I (ODELL, W . D . , DAUGHADAY, W . H . , Eds), J.B. Lippincott C o . , Philadelphia and Toronto (1971)1. DISCUSSION D. R O D B A R D : I think you have developed a v e r y fine method of curve fitting for RIA dose-response curves. However, i n weighing its advantages with respect to the logit-log method, it is important to bear i n mind the pros and cons of both methods. Since your discussion has tended to be somewhat unilateral, I would like to comment on the pros of the logit-log method. F i r s t of a l l , the logit-log model is essentially an application of linear regression, i . e. : Y 1 = a + bX» Although this model involves transformations of both the X and Y variables, it i s an extremely simple mathematical model, which i s readily adaptable to graphical analysis or to s m a l l desk-top calculators. Use of a linear model vastly simplifies the S t a t i s t i c a l analyses, e. g. calculation of the Standard e r r o r of the slope. Second, the logit-log model can be justified on the basis of the f i r s t order mass action law, although certain approximations are involved. T h i r d , the logit-log method i s successful, i . e. satisfactory linearity is obtained, i n more than 90% of a l l RIA Systems examined to date. It is a r a r e exception to the rule if the logit-log plot is not linear over the entire observable ränge. Fourth, the logit-log approach vastly facilitates calculation of potency estimates when both the Standard and unknown have been measured at 121 IAEA-SM-177/71 several dose levels. This corresponds to the calculation of p a r a l l e l - l i n e bioassay statistics by the methods of Finney and B l i s s . Thus, the logit-log method permits a combined test of p a r a l l e l i s m and potency estimate and of the confidence l i m i t s . I believe this is v e r y difficult, if not impossible, when using the "spline funetion" approach. Fifth, some of the deficiencies of the original logit-log method, which you correctly pointed out, have already been remedied. In the original version of the method, the zero dose response, i n terms of B/T or counts, was kept fixed. However, the methods of Burger, et a l . , of A r r i g u c c i , et a l . and of Healy permit the Computer to make an optimal adjustment of the value for ( B / T ) . L i k e w i s e , the value for non-speeifie counts (the lower asymptote) was kept constant i n the original logit-log method. However, the approach adopted by L e c l e r c q , Täljedal and Wold and by Healy p e r m i t the C o m p u t e r to e s t i m a t e t h i s value as w e l l . The a p p r o a c h which I w i l l p r e s e n t later today e m b o d i e s the advantages of a l l of these modifications, together with the often c r u c i a l ability to provide proper weighting to each point on the dose-response curve. Finally, when a l l eise f a i l s , one can fit a parabola in the logit-log co-ordinate system. We have adopted this approach quite successfully in those few assays which show a non-linear logit-log plot. This method is s t i l l far s i m p l e r , from a mathematical and Statistical point of view, than the use of "spline funetion" curve Utting. One additional technical comment: your method of weighting apparently weights points i n a manner inversely related to the observed Standard deviation of replicates of the response variable for a given dose. This method can be very unstable and unsatisfactory on aecount of the large sampling e r r o r in the sample Standard deviation based on only a few degrees of freedom. Only with ten or more replicates of y for each dose does this method become "well-behaved". This was shown by Jaquez et a l . a few years ago i n the Journal of B i o m e t r i c s . Accordingly, I would suggest that you plot 6y versus y, fit a smooth funetion to this relationship, and then use it as a basis for your weighting funetion. This should improve the efficiency of the curve fitting procedure. I. M A R S C H N E R : Many thanks for your comments, D r . Rodbard. I agree with you that the logit-log transformation is a procedure that is simple and relatively easy to understand from the mathematical point of view, and one which has been shown to be of value i n the S t a t i s t i c a l analysis of RIA S t a n d a r d curves. However, since it is difficult to gain insight into such various factors involved i n RIA as non-homogeneous antibody populations, cross-reaction, influences of the tracer due to varying specific activity and damage, and non-speeifie protein interference, we are reluctant to believe that the use of a mathematical method related to the principles of the f i r s t - o r d e r mass action law is justified. Indeed, the c r i t e r i a for applying such a principle w i l l be met only i n r a r e cases. In our experience, only half of a l l RIA S t a n d a r d curves can be made linear with the logit-log transformation. A n 1 2 3 0 4 3 1 2 3 4 Ref. [ 9] in paper SM-177/208. Ref. [10] in paper SM-177/208. Ref. [ 11] in paper SM-177/208. Ref.[8] in paper SM-177/208. 122 MARSCHNER et a l . attempt to fit a p a r a b o l a i n a l o g i t - l o g c o - O r d i n a t e S y s t e m i s n e i t h e r t h e o r e t i c a l l y s o u n d n o r often a p p l i c a b l e . For p u r p o s e s of q u a l i t y c o n t r o l we m a k e r e g u l ä r determinations of c o n t r o l s e r a , w h i c h we think i s m o r e i m p o r t a n t than the q u a l i t y c o n t r o l of S t a n d a r d c u r v e s . This i s one of the r e a s o n s why we do not need s o m e of the p a r a m e t e r s c a l c u l a t e d b y y o u r p r o g r a m , w h i c h , i n a n y case, a r e o n l y designed for the l a t t e r . A s I m e n t i o n e d i n m y p a p e r , we c a l c u l a t e , by a s u b - r o u t i n e , the r e g r e s s i o n between the S t a n d a r d c u r v e and r e c o v e r y c u r v e . This m e t h o d i s f r e e f r o m the d i f f i c u l t i e s i n h e r e n t i n the c a l c u l a t i o n of the r e g r e s s i o n b e t w e e n d i f f e r e n t S t a n d a r d c u r v e s , o r b e t w e e n S t a n d a r d c u r v e s and s e r u m dilution curves. A s r e g a r d s y o u r f i n a l p o i n t , I think I s h o u l d s t r e s s that w e i g h t i n g i n s p l i n e a p p r o x i m a t i o n has a c o m p l e t e l y d i f f e r e n t m a t h e m a t i c a l m e a n i n g f r o m the same t e r m w h e n u s e d f o r the c a l c u l a t i o n of a weighted r e g r e s s i o n in a n a l y s i s — a f e a t u r e w h i c h u n f o r t u n a t e l y i s liable to cause misunderstandings. Hence, the n u m b e r of the d e g r e e s of f r e e d o m plays no r o l e . Details of the w e i g h t i n g i n s p l i n e a p p r o x i m a t i o n a r e d e s c r i b e d i n the o r i g i n a l p a p e r o n the s u b j e c t b y R e i n s e n 5 . The g r e a t e s t a d v a n t a g e of s p l i n e a p p r o x i m a t i o n i s that we do not need to a n a l y s e , b y m e a n s of S t a t i s t i c a l methods, what k i n d of p r o c e d u r e ( i . e. logit, p a r a b o l a , four-component logit, etc.) w i l l fit f o r the i n d i v i d u a l c u r v e , and that we c a n a n a l y s e a l l S t a n d a r d c u r v e s d e r i v i n g f r o m RIA, C P B A , I R M A , o r two-site IRMA with this p r o c e d u r e . Statistical E . K E L L E R : By how m u c h do c a l c u l a t e d v a l u e s d i f f e r i n samples with v e r y l o w and v e r y h i g h a m o u n t s of h o r m o n e , when u s i n g (a) the l o g i t - l o g t r a n s f o r m a t i o n , and (b) the spline funetion? I. M A R S C H N E R : C l e a r l y , the d i f f e r e n c e s b e t w e e n the h o r m o n e v a l u e s which are read f r o m l o g i t - l o g o r f r o m s p l i n e a p p r o x i m a t e d S t a n d a r d c u r v e s depend on the k i n d of assay i n v o l v e d , and o n the s l o p e of the S t a n d a r d c u r v e . If, as i n a n ideal case, one gets a linear c u r v e b y l o g i t - l o g transformation, the differences do not e x c e e d 5%. If one does not o b t a i n l i n e a r i t y with the l o g i t - l o g t r a n s f o r m a t i o n , the m e t h o d s h o u l d not be u s e d at a l l , o r eise one should r e s t r i c t o n e s e l f to the l i n e a r a r e a i n the m i d d l e of the S t a n d a r d c u r v e , since the d e v i a t i o n at both ends i n c r e a s e s w i t h d i s t a n c e f r o m the m i d d l e ; such i s not the case, h o w e v e r , w i t h the s p l i n e a p p r o x i m a t i o n . 5 Ref. [ 1] of the paper.